Literature DB >> 11355303

Characterisation of molecular alterations in microdissected archival gliomas.

C Walker1, K A Joyce, J Thompson-Hehir, M P Davies, F E Gibbs, N Halliwell, B H Lloyd, Y Machell, M M Roebuck, J Salisbury, D R Sibson, D Du Plessis, J Broome, M L Rossi.   

Abstract

Classification of gliomas according to their molecular characteristics may be important in future histopathological diagnosis. However, gliomas frequently display heterogeneity at the histological, biological and molecular level. In this study of archival diagnostic gliomas, precision microdissection was used to enrich samples in the most malignant cells or to investigate intratumoural histological heterogeneity. Analysis of tumour samples microdissected from the most aggressive regions, representative of the histopathological diagnosis, revealed PTEN mutations in 4/14 anaplastic astrocytomas, 4/13 glioblastomas and 1 gliosarcoma, but not in 19 low-grade gliomas. Using a novel PCR procedure and direct sequence analysis of the entire coding sequence, TP53 mutations were detected in 1/3 pilocytic astrocytomas, 3/13 astrocytomas, 4/14 anaplastic astrocytomas, 5/13 glioblastomas and 1 gliosarcoma. All but one of the tumours with TP53 mutation showed p53 immunopositivity, but 5 low-grade and 10 high-grade gliomas had p53 protein nuclear accumulation in the absence of detectable mutation. p53 status was unrelated to p21 expression. Neither PTEN nor TP53 mutations influenced the proliferative index or microvessel density of high-grade astrocytomas. Unusual findings include: TP53 mutation in a juvenile pilocytic astrocytoma; TP53 and PTEN mutations in a de novo glioblastoma, a gliosarcoma with identical mutations in gliomatous and sarcomatous components, and an infratentorial anaplastic astrocytoma with an earlier supratentorial grade II astrocytoma bearing the same TP53 mutation but not the PTEN mutation or loss of heterozygosity (LOH) of 10q23. Similarly, the transition to high-grade histology was associated with acquisition of PTEN mutations and 10q23.3 LOH in two de novo high-grade tumours with regions of low-grade histology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11355303     DOI: 10.1007/s004010000259

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  7 in total

Review 1.  Update on molecular findings, management and outcome in low-grade gliomas.

Authors:  T David Bourne; David Schiff
Journal:  Nat Rev Neurol       Date:  2010-11-02       Impact factor: 42.937

2.  Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.

Authors:  Deborah R Smith; Cheng-Chia Wu; Heva J Saadatmand; Steven R Isaacson; Simon K Cheng; Michael B Sisti; Jeffrey N Bruce; Sameer A Sheth; Andrew B Lassman; Fabio M Iwamoto; Shih-Hsiu Wang; Peter Canoll; Guy M McKhann; Tony J C Wang
Journal:  J Neurooncol       Date:  2017-12-20       Impact factor: 4.130

Review 3.  MAPK pathway activation in pilocytic astrocytoma.

Authors:  David T W Jones; Jan Gronych; Peter Lichter; Olaf Witt; Stefan M Pfister
Journal:  Cell Mol Life Sci       Date:  2011-12-13       Impact factor: 9.261

4.  Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy.

Authors:  J Dunn; A Baborie; F Alam; K Joyce; M Moxham; R Sibson; D Crooks; D Husband; A Shenoy; A Brodbelt; H Wong; T Liloglou; B Haylock; C Walker
Journal:  Br J Cancer       Date:  2009-06-16       Impact factor: 7.640

5.  Giant parieto-occipital lobe pediatric gliosarcoma: Report of a rare entity and review of literature.

Authors:  Gautam Dutta; Robin Gupta; Manish Garg; Daljit Singh; Hukum Singh; Arvind K Srivastava; Anita Jagetia
Journal:  Surg Neurol Int       Date:  2018-05-29

6.  Machine Learning Models for Multiparametric Glioma Grading With Quantitative Result Interpretations.

Authors:  Xiuying Wang; Dingqian Wang; Zhigang Yao; Bowen Xin; Bao Wang; Chuanjin Lan; Yejun Qin; Shangchen Xu; Dazhong He; Yingchao Liu
Journal:  Front Neurosci       Date:  2019-01-11       Impact factor: 4.677

7.  Genetic alteration and clonal evolution of primary glioblastoma into secondary gliosarcoma.

Authors:  Jie Li; Yu-Hang Zhao; Su-Fang Tian; Cheng-Shi Xu; Yu-Xiang Cai; Kai Li; Yan-Bing Cheng; Ze-Fen Wang; Zhi-Qiang Li
Journal:  CNS Neurosci Ther       Date:  2021-10-04       Impact factor: 5.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.